Genotoxic activity of four metabolites of the soy isoflavone daidzein

被引:26
|
作者
Schmitt, E
Metzler, M
Jonas, R
Dekant, W
Stopper, H
机构
[1] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany
[2] Univ Karlsruhe, Inst Food Chem & Toxicol, D-76131 Karlsruhe, Germany
关键词
phytoestrogens; isoflavones; micronuclei;
D O I
10.1016/j.mrgentox.2003.08.003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Products containing phytoestrogens are increasingly promoted as the "natural" alternative to estrogen replacement therapy. In the present study, we have used the in vitro micronucleus assay in L5178Y mouse lymphoma cells to investigate the genotoxic potential of the isoflavone daidzein, and of four daidzein metabolites known to be formed in humans. Whereas no induction of micronuclei was observed with daidzein up to the limit of solubility (100 muM), all four daidzein metabolites, i.e. equol (2.3-fold induction at 100muM), O-desmethylangolensin (6.2-fold induction at 10 muM), 4',6,7-isoflavone (6.7-fold induction at 100 muM) and 3',4',7-isoflavone (8.2-fold induction at 100 muM) induced micronuclei in a concentration-dependent manner. Thus, both reductive and oxidative metabolites of the soy isoflavone daidzein exhibit genotoxic potential in vitro. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 50 条
  • [1] Oxidative metabolism enhances the cytotoxic and genotoxic properties of the soy isoflavone daidzein
    Baechler, Simone A.
    Schroeter, Anika
    Walker, Jessica
    Aichinger, Georg
    Marko, Doris
    MOLECULAR NUTRITION & FOOD RESEARCH, 2014, 58 (06) : 1269 - 1281
  • [2] In-vivoandin-silicotoxicity studies of daidzein: an isoflavone from soy
    Laddha, Ankit P.
    Murugesan, S.
    Kulkarni, Yogesh A.
    DRUG AND CHEMICAL TOXICOLOGY, 2022, 45 (03) : 1408 - 1416
  • [3] The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours
    Constantinou, AI
    White, BEP
    Tonetti, D
    Yang, YN
    Liang, WZ
    Li, WK
    van Breemen, RB
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (04) : 647 - 654
  • [4] Increased expression of catalase in human hepatoma cells by the soy isoflavone, daidzein
    Kampkoetter, Andreas
    Wiegand, Christian
    Timpel, Claudia
    Roehrdanz, Elke
    Chovolou, Yvonni
    Kahl, Regine
    Waetjen, Wim
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 102 (05) : 437 - 442
  • [5] The Soy Isoflavone Genistein And The Daidzein Metabolite Equol Are Neuroprotective In Experimental Stroke
    Schreihofer, Derek A.
    Ma, Yu-Lin
    STROKE, 2009, 40 (04) : E217 - E217
  • [6] Gut bacterial metabolism of the soy isoflavone daidzein: Exploring the relevance to human health
    Atkinson, C
    Frankenfeld, CL
    Lampe, JW
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2005, 230 (03) : 155 - 170
  • [8] Soy isoflavone metabolites: Lipoprotein binding and antioxidant properties
    Amendola, Donna M.
    Vinson, Joe A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238 : 258 - 258
  • [9] Antibacterial activity of the soy isoflavone genistein
    Hong, Hyunki
    Landauer, Michael R.
    Foriska, Mark A.
    Ledney, G. David
    JOURNAL OF BASIC MICROBIOLOGY, 2006, 46 (04) : 329 - 335
  • [10] Estrogenic activity of glycitein, a soy isoflavone
    Song, TT
    Hendrich, S
    Murphy, PA
    FASEB JOURNAL, 1997, 11 (03): : 3472 - 3472